id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-N-0356-0003,FDA,FDA-2021-N-0356,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-12-30T05:00:00Z,2021,12,2021-12-30T05:00:00Z,,2021-12-30T14:31:08Z,2021-28362,0,0,0900006484f005d1
FDA-2021-N-0356-0002,FDA,FDA-2021-N-0356,"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment and Operation of Clinical Trial Data
Monitoring Committees",Notice,30 Day Proposed Information Collection,2021-08-25T04:00:00Z,2021,8,2021-08-25T04:00:00Z,2021-09-25T03:59:59Z,2021-08-25T13:05:15Z,2021-18235,0,0,0900006484ca3076
FDA-2021-N-0356-0001,FDA,FDA-2021-N-0356,"Agency Information Collection 
Activities; Proposed Collection; 
Comment Request; Establishment and 
Operation of Clinical Trial Data 
Monitoring Committees",Notice,60 Day Proposed Information Collection,2021-04-29T04:00:00Z,2021,4,2021-04-29T04:00:00Z,2021-06-29T03:59:59Z,2021-04-29T13:18:26Z,2021-08963,0,0,0900006484abc32f